Oddity Tech Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 net revenue declined 26% year-over-year due to a technical issue with the largest ad partner, causing high CPA and reduced new customer acquisition. Remediation efforts are showing early signs of improvement, and full-year adjusted EBITDA is expected to be positive.
Fiscal Year 2025
-
Delivered record 2025 results with 25% revenue growth and strong repeat sales, but faces a temporary setback in 2026 due to sharply higher user acquisition costs from ad platform algorithm changes. Remediation is underway, with normalization expected in H2.
-
Q3 delivered 24% revenue and EPS growth, surpassing guidance, with strong performance from Il Makiage and SpoiledChild and the launch of METHODIQ. Full-year guidance was raised, and international revenue grew 40% year-over-year, while repeat sales and gross margins remained robust.
-
The company leads the direct-to-consumer beauty sector with strong online growth, high repeat sales, and a robust innovation pipeline. New brands, international expansion, and proprietary R&D drive future growth, while disciplined capital allocation and margin targets remain central.
-
The company’s agile, tech-driven direct-to-consumer model supports strong growth, with multiple brands scaling rapidly and international expansion set for 2025. Innovation through ODDITY Labs and disciplined capital allocation underpin a long-term goal of 20% annual revenue growth and high profitability.
-
Revenue grew 26% year-over-year in H1 2025, with strong Q2 results and robust free cash flow. Guidance for 2025 was raised, with new brand launches and international expansion driving future growth. Brand 3's Q4 launch targets the medical-grade dermatology market.
-
Q1 2025 delivered 27% revenue growth and record profitability, prompting raised full-year guidance. D2C and international expansion, new brand launches, and tech investments drive momentum, with strong cash flow and limited tariff risk supporting future growth.
Fiscal Year 2024
-
Delivered 27% revenue growth and 40% adjusted EBITDA growth in 2024, driven by strong repeat sales and double-digit growth across both major brands. Investments in AI, biotech, and new brands position the business for continued outperformance, with 2025 guidance reaffirmed for 20% revenue and EBITDA margin growth.
-
A leading online beauty platform leverages technology, data, and proprietary innovation to drive growth, aiming for billion-dollar brands and global expansion. Strong repeat business, high margins, and a robust balance sheet support its strategy, with AI and vision tools enhancing customer experience and product development.
-
-
Q3 saw 26% revenue growth, record profitability, and strong cash flow, driven by high repeat rates and increased AOV. 2024 guidance was raised, with continued investment in technology and new brands, while international expansion remains a major future opportunity.
-
Record Q2 and H1 2024 with 28% revenue growth, strong margins, and high repeat sales. Raised full-year guidance, continued investment in new brands and science, and announced a new Chief Science Officer. No signs of consumer weakness; share buybacks ongoing.